Lonza Walkersville
✓ Verified ManufacturerAbout
Lonza Walkersville operates as the largest manufacturing site for Lonza Bioscience in Maryland, serving as a critical hub for pharmaceutical and biotechnology production. Located in Walkersville, this 116-acre facility employs over 500 professionals and runs continuous three-shift operations to meet global healthcare demands. The Walkersville site specializes in manufacturing essential bioscience products including cell culture media for large-scale biologics production, primary cells, and cell culture tools that support life science research worldwide. A key focus area is endotoxin assay production, where the facility manufactures materials required to assess endotoxin levels in all injectable pharmaceutical products and medical devices, ensuring patient safety across the industry. As part of Lonza Group, a preferred global partner to pharmaceutical and biotech markets, the Walkersville facility supports the company's four core divisions: Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients. The site combines clinical-to-commercial manufacturing capabilities with advanced bioprocess technologies, enabling customers to deliver innovative medicines that treat a wide range of diseases. With operations dating back to 1974 and Lonza ownership since 2007, the Walkersville facility represents decades of pharmaceutical manufacturing expertise. The company continues investing in facility expansion with sustainable technologies, positioning itself as a leading contract development and manufacturing organization serving the global healthcare industry from its strategic Maryland location.